Literature DB >> 2646917

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

.   

Abstract

Atherosclerosis Risk in Communities (ARIC) is a new prospective study to investigate the etiology of atherosclerosis and its clinical sequelae and variation in cardiovascular risk factors, medical care, and disease by race, sex, place, and time. In each of four US communities--Forsyth County, North Carolina, Jackson, Mississippi, suburbs of Minneapolis, Minnesota, and Washington County, Maryland--4,000 adults aged 45-64 years will be examined twice, three years apart. ARIC has coordinating, ultrasound, pulmonary, and electrocardiographic centers and three central laboratories. Three cohorts represent the ethnic mix of their communities; the Jackson cohort, its black population. Examinations include ultrasound scanning of carotid and popliteal arteries; lipids, lipoproteins, and apolipoproteins assayed in the Lipid Laboratory; and coagulation, inhibition, and platelet and fibrinolytic activity assayed in the Hemostasis Laboratory. Surveillance for coronary heart disease will involve review of hospitalizations and deaths among community residents aged 35-74 years. ARIC aims to study atherosclerosis by direct observation of the disease and by use of modern biochemistry.

Entities:  

Mesh:

Year:  1989        PMID: 2646917

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  1803 in total

1.  Outcome-dependent sampling with interval-censored failure time data.

Authors:  Qingning Zhou; Jianwen Cai; Haibo Zhou
Journal:  Biometrics       Date:  2017-08-03       Impact factor: 2.571

2.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

3.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

4.  Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lucy S Witt; Jason Rotter; Sally C Stearns; Rebecca F Gottesman; Anna M Kucharska-Newton; A Richey Sharrett; Lisa M Wruck; Jan Bressler; Carla A Sueta; Patricia P Chang
Journal:  J Gen Intern Med       Date:  2018-07-20       Impact factor: 5.128

5.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

6.  Electrocardiographic QRS-T angle and the risk of incident silent myocardial infarction in the Atherosclerosis Risk in Communities study.

Authors:  Zhu-Ming Zhang; Pentti M Rautaharju; Ronald J Prineas; Larisa Tereshchenko; Elsayed Z Soliman
Journal:  J Electrocardiol       Date:  2017-05-04       Impact factor: 1.438

7.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

8.  Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study.

Authors:  Jonathan Rubin; Vijay Nambi; Lloyd E Chambless; Michael W Steffes; Stephen P Juraschek; Josef Coresh; A Richey Sharrett; Elizabeth Selvin
Journal:  Atherosclerosis       Date:  2012-09-13       Impact factor: 5.162

9.  Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.

Authors:  L M Steffen; M Cushman; J M Peacock; S R Heckbert; D R Jacobs; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

10.  Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Authors:  Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh
Journal:  Kidney Int       Date:  2017-08-31       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.